Drug Trial Radar · NCT07456033
A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 Asthma
Last checked: Nov 20, 2026Latest source record: Aug 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
456
Planned (sponsor's estimate)
Start
Mar 13, 2026
Primary completion
Sep 23, 2030
Study completion Sep 23, 2030
Sponsor
- Lead sponsor
- GlaxoSmithKlineGSK (GSK)
- Sponsor type
- Industry
- First posted
- Mar 6, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 12 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The aim of this study is to evaluate the efficacy of depemokimab administered as an adjunctive therapy, in participants with Type 2 asthma at risk of exacerbations compared to the guideline recommended standard of care (SoC).
Conditions
- Asthma
Interventions
DepemokimabDrug
Depemokimab will be administered
PlaceboDrug
Placebo will be administered
Primary outcomes
What the sponsor says the trial is designed to measure.
- Annualized rate of clinically significant exacerbationsTime frame: Up to Week 156
Locations
17 sites in 2 countries. Site status is shown where the registry gives one.
GSK Investigational Site
Little Rock, Arkansas · Recruiting
GSK Investigational Site
Newport Beach, California · Recruiting
GSK Investigational Site
Aurora, Colorado · Recruiting
GSK Investigational Site
Aventura, Florida · Recruiting
GSK Investigational Site
Kissimmee, Florida · Recruiting
GSK Investigational Site
Lake Worth, Florida · Recruiting
GSK Investigational Site
Miami, Florida · Recruiting
GSK Investigational Site
Miami, Florida · Recruiting
GSK Investigational Site
Miami, Florida · Recruiting
GSK Investigational Site
Shreveport, Louisiana · Recruiting
GSK Investigational Site
Oklahoma City, Oklahoma · Recruiting
GSK Investigational Site
DuBois, Pennsylvania · Recruiting
GSK Investigational Site
Wyomissing, Pennsylvania · Recruiting
GSK Investigational Site
Rapid City, South Dakota · Recruiting
GSK Investigational Site
San Antonio, Texas · Recruiting
GSK Investigational Site
Burke, Virginia · Recruiting
GSK Investigational Site
Bradford, United Kingdom · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.